Comparison of cytomegalovirus antigenemia and shell vial culture in allogeneic marrow transplantation recipients receiving ganciclovir prophylaxis

Bone Marrow Transplantation

Volumn 19, Issue 1, 1997, Pages 37-41

  Nicholson, V A ^a   Whimbey, E ^a   Champlin, R ^a   Abi Said, D ^a   Przepiorka, D ^a   Tarrand, J ^a   Chan, K ^a   Bodey, G P ^a   Goodrich, J M ^b  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b SOUTHERN ILLINOIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Antigenemia; Bone marrow transplant; CMV; Diagnosis; Viremia

Indexed keywords

ANTIVIRUS AGENT; GANCICLOVIR; VIRUS ANTIGEN;

ADOLESCENT; ADULT; ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; CHILD; CONTROLLED STUDY; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; DIAGNOSTIC VALUE; FEMALE; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; PATIENT MONITORING; PRIORITY JOURNAL; VIRUS CULTURE;

EID: 0031028555     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1700612     Document Type: Article

References (28)

1. Goodrich JM, Boeckh M, Bowden R. Strategies for the prevention of cytomegalovirus disease after marrow transplantation. Clin Infect Dis 1994; 19: 287-298.
2. Atkinson K, Downs K, Golenia M et al. Prophylactic use of ganciclovir in allogeneic bone marrow transplantation: absence of clinical cytomegalovirus infection. Br J Haematol 1991; 79: 57-62.
3. Yau JC, Dimopoulos MA, Huan SD et al. Prophylaxis of cytomegalovirus infection with ganciclovir in allogeneic marrow transplantation. Eur J Haematol 1994; 47: 371-376.
4. von Bueltzingsloewen A, Bordigoni P, Witz F et al. Prophylactic use of ganciclovir for allogeneic bone marrow transplant recipients. Bone Marrow Transplant 1993; 12: 197-202.
5. Goodrich JM, Bowden R, Kellar C, Meyers JD. Prevention of cytomegalovirus disease after allogeneic marrow transplant by ganciclovir prophylaxis. Ann Intern Med 1993; 117: 173-178.
6. Winston DJ, Ho WG, Bartoni K et al. Ganciclovir prophylaxis of cytomegalovirus infection and disease in allogeneic marrow transplants. Ann Intern Med 1993; 117: 179-184.
7. Schmidt GM, Horak DA, Niland JC et al. A randomized, controlled trial of prophylactic ganciclovir for cytomegalovirus pulmonary infection in recipients of allogeneic bone marrow transplants. New Engl J Med 1991, 324: 1005-1011.
8. Goodrich J, Mori M, Gleaves C et al. Early treatment with ganciclovir to prevent cytomegalovirus disease after allogeneic marrow transplant. New Engl J Med 1991; 325: 1601-1607.
9. Eisele H, Ehninger G, Hebart H et al. Polymerase chain reaction monitoring reduces the incidence of cytomegalovirus disease and the duration and side effects of antiviral therapy. Blood 1995; 86: 2815-2820.
10. van der Bij W, Schirm J, Torensma R et al. Comparison between viremia and antigenemia for the detection of cytomegalovirus in blood. J Clin Microbiol 1988; 26: 2531-2535.
11. Boland GJ, de Gast GC, Hene RJ et al. Early detection of active cytomegalovirus (CMV) infection after heart and kidney transplantation by testing for early antigenemia and influence of cellular immunity on the occurrence of CMV infection. J Clin Microbiol 1990; 28: 2069-2075.
12. van der Berg AP, Klompmaker IJ, Haagsma EB et al. Antigenemia in the diagnosis and monitoring of active cytomegalovirus infection after liver transplantation. J Infect Dis 1991; 164: 265-270.
13. Gerna G, Zipet D, Para M et al. Monitoring of human cytomegalovirus infections and ganciclovir treatment in heart transplant recipients by determination of viremia, antigenemia, and DNAemia. J Infect Dis 1991; 164: 488-498.
14. van der Bij W, Torensma R, VanSon WJ et al. Rapid immunodiagnosis of active cytomegalovirus infection by monoclonal antibody staining of blood leukocytes. J Med Virol 1988; 25: 179-188.
15. The TH, van der Ploeg M, van den Berg AP et al. Direct detection of cytomegalovirus in peripheral blood leukocytes. A review of the antigenemia assay and polymerase chain reaction. Transplantation 1992; 54: 193-198.
16. Grefte JMM, van der Gun BTF, Schmolke S et al. Cytomegalovirus antigenemia assay: identification of the viral antigen as the lower matrix protein. J Infect Dis 1992; 166: 683-684.
17. van der Giessen M, The TH, van Son WJ. Cytomegalovirus antigenemia assay. J Clin Microbiol 1991; 12: 2909-2910.
18. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 457-481.
19. Meyers JD, Flournoy N, Thomas ED. Risk factors for cytomegalovirus infection after human marrow transplantation. J Infect Dis 1986; 153: 478-488.
20. Meyers JD, Ljungman P, Fisher LD. Cytomegalovirus excretion as a predictor of cytomegalovirus disease after marrow transplantation: importance of cytomegalovirus viremia. J Infect Dis 1990; 162: 373-380.
21. Gleaves CA, Smith TF, Shuster EA, Pearson GR. Rapid detection of cytomegalovirus in MRC-5 cells inoculated with urine specimens by using low-speed centrifugation and monoclonal antibodies to an early antigen. J Clin Microbiol 1984; 19: 917-919.
22. Gleaves CA, Reed EC, Hackman RC, Meyers JD. Rapid diagnosis of invasive cytomegalovirus infection by examination of tissue specimens in centrifugation culture. Am J Clin Pathol 1987; 88: 354-358.
23. Boeckh M, Bowden RA, Goodrich JM et al. Cytomegalovirus antigenemia detection in peripheral blood leukocytes after allogeneic marrow transplantation. Blood 1992; 80: 1358-1364.
24. Atkinson K, Arthur C, Bradstock K et al. Prophylactic ganciclovir is more effective in HLA-identical family member marrow transplant recipients than in more heavily immunesuppressed HLA-identical unrelated donor marrow transplant recipients. Bone Marrow Transplant 1995; 16: 401-405.
25. Gerna G, Zipeto D, Parea M et al. Monitoring of human cytomegalovirus infection and ganciclovir treatment in heart transplant recipients by determination of viremia, antigenemia, and DNAemia. J Infect Dis 1991; 164: 488-498.
26. Erice A, Chou S, Biron KK et al. Progressive resistance due to ganciclovir-resistant cytomegalovirus in immunocompromised patients. New Engl J Med 1989; 320: 289-293.
27. Knox KK, Drobyski WR, Carrigan DR. Cytomegalovirus isolate resistant to ganciclovir and foscarnet from a marrow transplant patient. Lancet 1991, 337: 1292-1293.
28. Boivin G, Chou S, Quirk MR et al. Detection of ganciclovir resistance mutations and quantitation of cytomegalovirus (CMV) DNA in leukocytes of patients with fatal disseminated CMV disease. J Infect Dis 1996; 173: 523-528.